Young person and adult screening KPI data: Q3 summary factsheets (1 Oct to 31 Dec 2023)
Updated 19 September 2024
Applies to England
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/q3-1-oct-to-31-dec-2023-annb-and-ypa-screening-kpi-data/young-person-and-adult-screening-kpi-data-q3-summary-factsheets-1-oct-to-31-dec-2023
Please be aware that this data covers the time period through the COVID-19 pandemic. Provider performance should therefore be interpreted with caution.
In addition to this, some providers were justifiably not able to make timely data returns or validate their data in this period. We recommend looking at the historical trend data of services before the COVID-19 pandemic to help interpret the data.
This report should be read in conjunction with the full KPI data tables published each quarter.
1. Abdominal aortic aneurysm screening
1.1 KPI AA2: coverage: initial screen
National performance of AA2 (see standard AAA-S04) in Q3 was 62.6%. AA2 is an annual indicator and quarterly figures are cumulative from Q1 to Q4. England performance is shown in the trend graph below.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 208,278 | 332,916 | 62.6 | 100% |
| Region | Performance % |
|---|---|
| East of England | 72.5% |
| London | 57.0% |
| Midlands | 66.5% |
| North East and Yorkshire | 53.1% |
| North West | 58.0% |
| South East | 60.7% |
| South West | 73.4% |
| England | 62.6% |
1.2 KPI AA3: coverage: annual surveillance scan
National performance of AA3 (see standard AAA-S05) was withdrawn from publication in Q1 and Q2 2020 to 2021, and also Q1 2021 to 2022. This was due to the impact of the COVID-19 pandemic on screening activity that occurred during these periods.
The trend graph below shows that England AA3 in Q3 was 91.7%, above the acceptable threshold of 85%.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 3,227 | 3,519 | 91.7% | 100% |
| Region | Performance % |
|---|---|
| East of England | 91.8% |
| London | 87.5% |
| Midlands | 93.2% |
| North East and Yorkshire | 91.4% |
| North West | 89.5% |
| South East | 91.4% |
| South West | 93.5% |
| England | 91.7% |
1.3 KPI AA4: coverage: quarterly surveillance scan
National performance of AA4 (see standard AAA-S06) was withdrawn from publication in Q1 and Q2 2020 to 2021 due to the impact of the COVID-19 pandemic on screening activity. The trend graph below shows that England AA4 in Q3 2023 to 2024 was 93.0%, higher than the previous quarter and above the acceptable threshold of 90%.
27 out of 38 screening services met the acceptable threshold, and 17 of those met the achievable threshold of 95%.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 2,638 | 2,838 | 93.0% | 100% |
| Region | Performance % |
|---|---|
| East of England | 95.0% |
| London | 86.3% |
| Midlands | 93.9% |
| North East and Yorkshire | 92.4% |
| North West | 90.0% |
| South East | 93.1% |
| South West | 94.9% |
| England | 93.0% |
2. Diabetic eye screening
2.1 KPI DE1: uptake: routine digital screening
National performance of DE1 (see standard DES-S07) in Q3 was 79.9%, higher than the previous quarter. The trend graph below shows that England DE1 performance has been above the acceptable threshold of 75% for ten consecutive quarters. All 56 screening services submitted data. DE1 is an annual rolling figure.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 2,478,081 | 3,102,348 | 79.9% | 100% |
| Region | Performance % |
|---|---|
| East of England | 83.3% |
| London | 79.6% |
| Midlands | 76.9% |
| North East and Yorkshire | 78.7% |
| North West | 76.8% |
| South East | 82.0% |
| South West | 84.9% |
| England | 79.9% |
2.2 KPI DE2: test: timeliness of results letters
National performance of DE2 (see standard DES-S10) in Q3 was 98.0%, lower than the previous quarter. The trend graph below shows that England DE2 performance rose above the achievable threshold of 95%. All 56 screening services submitted data. 54 out of 56 services met the acceptable threshold of 70% and 49 met the achievable threshold of 95%.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 699,136 | 713,485 | 98.0% | 100% |
| Region | Performance % |
|---|---|
| East of England | 99.7% |
| London | 99.8% |
| Midlands | 99.1% |
| North East and Yorkshire | 91.8% |
| North West | 96.4% |
| South East | 99.7% |
| South West | 99.8% |
| England | 98.0% |
2.3 KPI DE3: intervention/treatment: timely consultation for people with diabetes who are screen positive
National performance of DE3 (see standard DES-S12) in Q3 was 65.7%, higher than the previous quarter. The trend graph below shows that England DE3 performance has remained below the acceptable threshold of 80% since 1 April 2019. All 56 screening services submitted data and 21 met the acceptable threshold.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 1,809 | 2,752 | 65.7% | 100% |
| Region | Performance % |
|---|---|
| East of England | 64.4% |
| London | 74.9% |
| Midlands | 73.1% |
| North East and Yorkshire | 58.0% |
| North West | 55.4% |
| South East | 67.2% |
| South West | 60.0% |
| England | 65.7% |
2.4 KPI DE4: uptake: repeat non-attenders
DE4 (see standard DES-S08) was introduced in 2022 to 2023.
In Q3 2023 to 2024, national performance of DE4 was 10.0%. DE4 is a KPI where a lower performance is better.
All 56 screening services submitted data. 18 met the acceptable threshold of 8.0% and 5 of them met the achievable threshold of 5.0%.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 221,706 | 2,215,101 | 10.0% | 100% |
| Region | Performance % |
|---|---|
| East of England | 7.5% |
| London | 9.1% |
| Midlands | 12.4% |
| North East and Yorkshire | 10.1% |
| North West | 11.8% |
| South East | 9.6% |
| South West | 7.5% |
| England | 10.0% |
3. Bowel cancer screening
3.1 KPI BCS1: uptake
National performance of BCS1 (see standard BCSP-S02) in Q3 was 66.0%, lower than the previous quarter. Publication of BCS1 was withdrawn for Q1 2020 to 2021 due to the impact of COVID-19 on screening activity. The trend graph below shows that England BCS1 performance has remained above the acceptable threshold of 52% since 1 April 2019.
Out of 64 screening services, 63 of them met the acceptable threshold and 57 met the achievable threshold of 60%.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 1,157,536 | 1,754,860 | 66.0% | 100% |
| Region | Performance % |
|---|---|
| East of England | 69.3% |
| London | 56.9% |
| Midlands | 66.5% |
| North East and Yorkshire | 67.5% |
| North West | 63.9% |
| South East | 67.9% |
| South West | 70.5% |
| England | 66.0% |
3.2 KPI BCS2: coverage
National performance of BCS2 (see standard BCSP-S01) in Q2 was 71.8%, lower than the previous quarter. See the corresponding data tables for Q4 2022 to 2023 for full details.
BCS2 is available 6 months (2 quarters) in arrears. The trend graph below shows England BCS2 performance since 1 April 2019. There are no thresholds set for this KPI.
Q2 Coverage ranged from 63.2% in London to 75.5% in the South West.
Quarter 2 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 July to 30 September 2023 | 6,710,913 | 9,346,186 | 71.8% | 100% |
| Region | Performance % |
|---|---|
| East Midlands | 73.0% |
| East of England | 73.3% |
| London | 63.2% |
| North East | 73.8% |
| North West | 70.8% |
| South East | 74.0% |
| South West | 75.5% |
| West Midlands | 70.4% |
| Yorkshire and the Humber | 73.6% |
| England | 71.8% |
4. Breast screening
4.1 KPI BS1: uptake
National performance of BS1 (see standard BSP-S03) in Q3 was 66.6%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.
Provisional quarterly data should be used with caution to measure performance as it will contain a proportion of women who were invited but have not yet attended the appointment. Data on this indicator will only be accurate 6 months after the end of the reporting period.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 393,308 | 590,355 | 66.6% | 100% |
| Region | Performance % |
|---|---|
| East of England | 69.1% |
| London | 58.4% |
| Midlands | 66.8% |
| North East and Yorkshire | 65.7% |
| North West | 69.1% |
| South East | 71.4% |
| South West | 65.0% |
| England | 66.6% |
4.2 KPI BS2: uptake: screening round length
National performance of BS2 (see standard BSP-S04) in Q3 was 96.7%. The England trend graph below shows that publication of this KPI was withdrawn from Q1 to Q4 2020 to 2021 as there were issues with data quality due to the impact of the COVID-19 pandemic on screening services.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 406,400 | 420,064 | 96.7% | 100% |
| Region | Performance % |
|---|---|
| East of England | 94.8% |
| London | 99.2% |
| Midlands | 97.9% |
| North East and Yorkshire | 96.4% |
| North West | 96.3% |
| South East | 96.3% |
| South West | 95.7% |
| England | 96.7% |
5. Cervical screening
5.1 KPI CS1: coverage under 50 years
National performance of CS1 (see standard CSP-S01) in Q3 was 67.2%, higher than the previous quarter. The trend graph below shows that CS1 performance has remained below the acceptable threshold of 80% since 1 April 2019.
None of the 106 sub-ICBs met the acceptable threshold.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 7,234,690 | 10,771,875 | 67.2% | 100% |
| Region | Performance % |
|---|---|
| East of England | 70.3% |
| London | 60.3% |
| Midlands | 67.5% |
| North East and Yorkshire | 70.2% |
| North West | 67.6% |
| South East | 69.0% |
| South West | 71.2% |
| England | 67.2% |
5.2 KPI CS2: coverage 50 years and above
National performance of CS2 (see standard CSP-S02) in Q3 was 74.7%, lower than the previous quarter. The trend graph below shows that CS2 performance has remained below the acceptable threshold of 80% since 1 April 2019.
None of the 106 sub-ICBs met the acceptable threshold.
Quarter 3 performance
| Reporting period | Numerator | Denominator | Performance % | Completeness of data % |
|---|---|---|---|---|
| 1 October to 31 December 2023 | 4,053,405 | 5,426,665 | 74.7% | 100% |
| Region | Performance % |
|---|---|
| East of England | 76.4% |
| London | 71.6% |
| Midlands | 75.0% |
| North East and Yorkshire | 75.9% |
| North West | 73.3% |
| South East | 75.0% |
| South West | 76.2% |
| England | 74.7% |